MedTrace Logo

The Influence of Specialized Food Products Based on Ice-Cream on Esophageal Motility

NCT07121803 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-08-14

No results posted yet for this study

Summary

This study aims to assess the influence of specialized products based on ice cream on esophageal motility

Conditions

  • Ineffective Esophageal Motility
  • GERD (Gastroesophageal Reflux Disease)

Interventions

OTHER

specialized food based on ice cream, order 1

Order of intervention: 1. ice cream with 0.014% brazzein, 6% maltitol and 8% oligofructose; 2: ice cream with 0.014% brazzein, 7.5% erythritol, 2.5% maltitol and 4% inulin; 3: standard ice cream (12% fat)

OTHER

specialized food based on ice cream, order 2

1. ice cream with 0.014% brazzein, 7.5% erythritol, 2.5% maltitol and 4% inulin; 2. ice cream with 0.014% brazzein, 6% maltitol and 8% oligofructose; 3. standard ice cream (12% fat)

OTHER

specialized food based on ice cream, order 3

1. standard ice cream (12% fat) 2. ice cream with 0.014% brazzein, 6% maltitol and 8% oligofructose 3. ice cream with 0.014% brazzein, 7.5% erythritol, 2.5% maltitol and 4% inulin

Sponsors & Collaborators

  • Russian Science Foundation

    collaborator OTHER

  • Group of companies EFKO

    collaborator UNKNOWN

  • Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology

    lead OTHER

Principal Investigators

  • Sergey Morozov, MD, PhD · Federal Research Center of Nutrition and Biotechnology

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07121803 on ClinicalTrials.gov